A platform trial published in The Lancet Neurology looks at the efficacy of anti-amyloid drugs that could delay the onset of Alzheimer’s disease. Prof Robert Howard, Professor of Old Age Psychiatry, ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...
A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...
Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...
A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Many men tolerate finasteride well, but some have complications including symptoms that persist after stopping the drug.
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback